Ankle Exosuit Training for Stroke Rehabilitation
Trial Summary
What is the purpose of this trial?
This study focuses on investigating exosuit technology by evaluating its ability to provide a gait-restorative effect delivered in both clinic and community settings. The exosuit provides dynamic dorsiflexion and plantarflexion assist during walking. We will determine the effect of training parameters of intensity, repetition, and gait quality which are all key parameters associated with experience-dependent neuroplasticity. The other objective is to determine the effect of this intervention on community walking activity, walking speed, walking distance, and locomotor mechanics and energetics.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Ankle Exosuit Training for stroke rehabilitation?
Research shows that using an ankle exosuit can improve walking ability in stroke patients by enhancing propulsion and ground clearance, which are common walking issues after a stroke. Studies also indicate that exosuits can help increase walking speed and step count, suggesting they may be a useful tool for stroke rehabilitation.12345
Is Ankle Exosuit Training safe for humans?
Studies suggest that exosuits, including ankle exosuits, are generally safe for use in stroke rehabilitation. However, in a study involving spinal cord injury patients, some experienced symptomatic hypotension (low blood pressure), indicating that while generally safe, monitoring for adverse events is important.12346
How does Ankle Exosuit Training differ from other stroke rehabilitation treatments?
Ankle Exosuit Training is unique because it uses a wearable robotic device to assist the paretic (weakened) ankle, improving walking mechanics and propulsion in stroke patients. Unlike traditional passive devices, the exosuit actively supports the ankle during walking, potentially enhancing gait and reducing the energy cost of walking.12378
Research Team
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Eligibility Criteria
This trial is for adults aged 18-80 who had a stroke at least 6 months ago, can walk unassisted for two minutes, and have certain heart rate and blood pressure levels. It's not suitable for those with severe communication issues, specific visual impairments, recent dizziness, skin wounds where the device fits, significant artery disease or unresolved clots.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo an 18 session training protocol with the ReWalk Soft Exosuit to optimize timing and assess gait-restorative effects
Follow-up
Participants are monitored for changes in gait speed, walking distance, and functional capacity post-intervention
Treatment Details
Interventions
- Ankle Exosuit Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arun Jayaraman, PT, PhD
Lead Sponsor
U.S. Department of Education
Collaborator